Profile: Wockhardt Ltd (WCKH.BO)
WCKH.BO on Bombay Stock Exchange
6 May 2016
6 May 2016
Change (% chg)
Wockhardt Limited (Wockhardt) is an India-based pharmaceutical and biotechnology company. The Company is focused in biotech research program for the development of diabetes related treatment. It has approximately three research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Clopione, Decdan, Gleedox, H.B Rich, Immumod, Kelo-Cote, Lanagesic, Manix Herbal, Nadimix, Obax, Platin, Rozuone, Sammy, TeMax, Vitix, Wepox and Zedex, among others. It markets insulin and glargine, under the brands Wosulin and Glaritus respectively. It offers Wosulin in the form of a disposable pen, a Wockhardt device. It offers glargine for diabetologists and diabetic patients. Its drug candidates WCK 771, WCK 2349 and WCK 4873 received qualified infectious disease product (QIDP) status in the United States.
Bandra Kurla Complex, Bandra (Ea